ES2115178T3 - Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica. - Google Patents

Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.

Info

Publication number
ES2115178T3
ES2115178T3 ES94402169T ES94402169T ES2115178T3 ES 2115178 T3 ES2115178 T3 ES 2115178T3 ES 94402169 T ES94402169 T ES 94402169T ES 94402169 T ES94402169 T ES 94402169T ES 2115178 T3 ES2115178 T3 ES 2115178T3
Authority
ES
Spain
Prior art keywords
derivatives
indanotrionas
hydrazides
therapeutic application
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94402169T
Other languages
English (en)
Inventor
Stephanie Desquand
Michel Finet
Marquer Florence Le
Norbert Olivier Tembo
Jean-Luc Torregrosa
Sylvie Yannic-Arnoult
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Application granted granted Critical
Publication of ES2115178T3 publication Critical patent/ES2115178T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/84Hydrazones having doubly-bound carbon atoms of hydrazone groups being part of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/88Nicotinoylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LOS DERIVADOS DE LA PRESENTE INVENCION RESPONDEN A LA FORMULA GENERAL (I) EN LA QUE AI ES UN CICLO AROMATICO SUSTITUIDO O NO SUSTITUIDO, UN CICLO HETEROAROMATICO CON UNO O VARIOS HETEROATOMOS CON LA EXCLUSION DEL RADICAL FENILO Y DEL RADICAL PIRIDILO.
ES94402169T 1993-10-01 1994-09-29 Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica. Expired - Lifetime ES2115178T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311720A FR2710641B1 (fr) 1993-10-01 1993-10-01 Dérivés d'indane triones et d'hydrazides et leur application thérapeutique.

Publications (1)

Publication Number Publication Date
ES2115178T3 true ES2115178T3 (es) 1998-06-16

Family

ID=9451459

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94402169T Expired - Lifetime ES2115178T3 (es) 1993-10-01 1994-09-29 Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.

Country Status (5)

Country Link
EP (1) EP0650958B1 (es)
AT (1) ATE163359T1 (es)
DE (1) DE69408622T2 (es)
ES (1) ES2115178T3 (es)
FR (1) FR2710641B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900008301A1 (it) * 2019-06-06 2020-12-06 Epi C S R L Modulatori di sirtuine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508375A (ja) * 1992-04-03 1994-09-22 イノテラ インダン−1,3−ジオンおよびインダン−1,2,3−トリオンの誘導体、それらの調製方法およびそれらの治療上の使用

Also Published As

Publication number Publication date
DE69408622D1 (de) 1998-04-02
EP0650958B1 (fr) 1998-02-25
EP0650958A1 (fr) 1995-05-03
DE69408622T2 (de) 1998-10-15
FR2710641A1 (fr) 1995-04-07
ATE163359T1 (de) 1998-03-15
FR2710641B1 (fr) 1995-12-22

Similar Documents

Publication Publication Date Title
YU101791A (sh) Supstituisani ftalidi i heterociklični ftalidi
DE69213256T2 (de) Organische salze von n, n'-diacetylcystin
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ATE171068T1 (de) Chinoloncarbonsäurederivate, ihre herstellung und ihre verwendung als zelladhäsion inhibitoren
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
DE69418243D1 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
DE69104615D1 (de) Diphenylpiperazinderivat.
NZ260159A (en) N-bicyclic nitrogen compounds and medicaments
DE69514284D1 (de) Herstellung von Catechol-Estrogen-Derivaten
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ES2062389T3 (es) Acidos glutaramicos sustituidos y sus derivados.
DE69126758D1 (de) Benzamid-Derivate
ATE83481T1 (de) Fuenfgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
ES2115178T3 (es) Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.
DE69302087D1 (de) Trazodone alkyl derivate mit zns wirkung
FI910511A (fi) Foerfarande foer framstaellning av substituerade b-diketoner.
MX9201931A (es) Nuevos derivados de tiazol.
DE69221897T2 (de) Herstellung von 2-(pyridyl)ethyl substituierte phosphor-verbindungen
DE69222983T2 (de) Heterocyclische Derivate
BR9306924A (pt) Derivados de 1,3-oxazolidina pirdil-substituídos oidetos de 1,2,4-ditioz lio de novos compostos de partida
FI953518A (fi) Uudet substituoidut tiosemikarbatsonijohdannaiset
SU1823451A1 (ru) 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий
NO894478D0 (no) Heterocykliske derivater av 1,2-difluorbenzen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 650958

Country of ref document: ES